Crawford Defends Interventions In Product Liability Suits
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will continue to defend its authority over drug approvals by supporting federal preeminence in state product liability suits, Acting Commissioner Lester Crawford said Aug. 2 at a National Press Club luncheon in Washington, D.C